ReviewFrontiers in endocrinology2025
Therapeutic potential of traditional Chinese medicine in diabetic cardiomyopathy: a review.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms, Current Treatment and Therapeutic Potential of Plant Antioxidants.Antioxidants (Basel, Switzerland) · 2026Review
- Traditional Chinese medicine in the treatment of diabetic kidney disease: the mechanisms of signaling pathways regulations.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic cardiomyopathy (DCM) is a common cardiovascular complication that could lead to changes in cardiac structure and function. It is one of the leading causes of death in diabetic patients. Due to the complex pathogenesis of DCM, there is currently no specific drug or prophylactic agent to treat DCM, so there is an urgent need to identify new therapeutic agents or complementary and alternative therapies for DCM. Although Traditional Chinese medicine (TCM) has some limitations, it has the unique advantages of multi-level, multi-target and few side effects, which could effectively deal with the complex pathological mechanism of DCM. Growing evidence suggests that inflammation, oxidative stress, myocardial fibrosis and autophagy are the main pathological mechanisms of DCM. This study will shed light on the prospects of TCM treatment of DCM from the above perspective in order to provide more ideas and evidence for the clinical use of TCM for the prevention and treatment of DCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.